Previous 10 | Next 10 |
Aditxt (NASDAQ: ADTX) , a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, has signed an asset purchase agreement with Cellvera Ltd. According to the announcement, the agreement gives Aditxt a 50% ownership in G Response Aid FZE;...
This agreement is a significant step for Aditxt as it expands its portfolio to include innovative therapies for infectious diseases; Aditxt will partner with global logistics leader Agility to address a growing global market need for effective antivirals Aditxt,® Inc. ...
A survey of 742 individuals found that 16% had experienced serious reactions to gel polish. A warning on this issue was first issued in 2018 by the British Association of Dermatologists following reports of a significant increase in allergic skin reactions linked to the chemicals. Dermatologist...
Aditxt (NASDAQ: ADTX) , an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, has released a shareholder update outlining its three innovation programs and strategic M&A initiatives. The update notes that subsidiary...
Aditxt,® Inc, (NASDAQ: ADTX) (“Aditxt” or the “Company”), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, is pleased to provide an important update regarding its three innovation programs and stra...
Last month, the U.S. government revealed its plan to overhaul the country’s organ transplant system. The system isn't meeting the needs of many patients, with about 104,000 individuals awaiting organ transplants on the list. It is said that 17 individuals die daily waiting for a transpl...
The recent coronavirus pandemic underscored how dangerous viral infections can be when they get out of hand. The communicable respiratory disease took nearly 7 million lives , bringing the globe to a standstill as countries shut their borders to prevent infections. In a recent study, researchers...
It seems that people are becoming more allergic to foods with every passing year. The West especially has seen a steady increase in the number of children who are allergic to different foods in recent decades, with 40% of American children now having some kind of food allergy. In the United K...
Although thousands of people require organ transplants every year to address various conditions that cause organ failure, the supply of organs is not nearly enough to meet demand. As a result, people often spend years on waitlists, biding their time until they are lucky enough to receive a compat...
Japanese researchers have discovered a chemical compound that could finally make the treatment of autoimmune disorders such as multiple sclerosis and rheumatoid arthritis possible. Autoimmune diseases occur when the immune system cannot differentiate between the body’s own cells and fore...
News, Short Squeeze, Breakout and More Instantly...
ADiTx Therapeutics Inc. Company Name:
ADTX Stock Symbol:
NASDAQ Market:
ADiTx Therapeutics Inc. Website:
SAN DIEGO, July 25, 2024 (GLOBE NEWSWIRE) -- Women’s health innovator Evofem Biosciences, Inc. (“Evofem” or “the Company”) (OTCQB: EVFM) today announced that Saundra Pelletier, Chief Executive Officer and Amy Raskopf, Chief Business Development Officer...
Appili, with a commercial-stage pipeline, has raised CAD $100M towards developing therapeutics for the global infectious disease and biodefense markets. Subject to the renewal of certain legislation, two programs are potentially eligible for FDA Priority Review Vouchers Aditxt, Inc. (...
Evofem Biosciences Inc. (OTCQB: EVFM) , a company commercializing innovative products to address unmet needs in women's sexual and reproductive health, has signed a license and supply agreement for the Middle East rights to Phexxi(R), Evofem's FDA-approved, hormone-free contra...